Bangkok, March 3, 2015 ? The SEC organized ?1st SEC Working Papers Forum, 2015? where the Faculty of Commerce and Accountancy, Chulalongkorn University presented research papers on ?Impacts of

Thai Capital Market and Economic Growth.” In addition, the research team from Thammasat University led by Prof. Witawat Rungruangphon and Mr. Weerapong Kitiwong, PhD., presented the results of the Value

auditor of listed SOEs, has joined the project to enhance its audit quality on par with the same standards. The World Bank will assign an expert on international audit standards to train OAG officers and

an indication of the general purpose of such commitments and the anticipated sources of funds needed to fulfill such commitments. 20 C. Research and Development Provide a description of the issuer's

FINANCIAL REVIEW AND PROSPECTS A. Operating Results ผลการดําเนินงาน B. Liquidity and Capital Resources แหลงเงินทุนและสภาพคลอง C. Research & Development, Patents and License, etc. การวิจัยและพัฒนา D. Trend

Summary Part 2 The Issuer 2.1 Objectives of the fund 2.2 Business operation 1. Policy and overview of business operation 2. Nature of business operation 3. Risk factors 4. Research and development 5. Assets

Company overall. (11) Opinion of the Audit Committee and/or Company’s Directors that is different than the opinion of the Board of Directors : None (12) Opinion of the Independent Expert : None (13

Laboratory and Research Center (“AMARC”). Costs and Expenses  The Company reported the consolidated costs and expenses for Q1/2019 of Baht 345.54 million, nearby of Q1/2018 of Baht 345.61 million decreased by

booked in year 2018 for chronic diseases were then subtracted accordingly. However, the service revenues (mainly received from Asia Medical and Agricultural Laboratory and Research Center Co., Ltd “AMARC

to the hospital. In regard to the subsidiary, Asia Medical & Agricultural Laboratory and Research Center (“AMARC”), its service revenues grew by 12.60% as it provides laboratory testing and analyzing